327 related articles for article (PubMed ID: 21324349)
1. Behavioral, neuropsychiatric and cognitive disorders in Parkinson's disease patients with and without motor complications.
Solla P; Cannas A; Floris GL; Orofino G; Costantino E; Boi A; Serra C; Marrosu MG; Marrosu F
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1009-13. PubMed ID: 21324349
[TBL] [Abstract][Full Text] [Related]
2. Cognitive and behavioural impairment in Parkinson's disease.
Merims D; Freedman M
Int Rev Psychiatry; 2008 Aug; 20(4):364-73. PubMed ID: 18925485
[TBL] [Abstract][Full Text] [Related]
3. Impaired awareness of movement disorders in Parkinson's disease.
Amanzio M; Monteverdi S; Giordano A; Soliveri P; Filippi P; Geminiani G
Brain Cogn; 2010 Apr; 72(3):337-46. PubMed ID: 19914762
[TBL] [Abstract][Full Text] [Related]
4. The impact and management of nonmotor symptoms of Parkinson's disease.
Lyons KE; Pahwa R
Am J Manag Care; 2011 Oct; 17 Suppl 12():S308-14. PubMed ID: 22087551
[TBL] [Abstract][Full Text] [Related]
5. Treatment of advanced Parkinson's disease.
Diamond A; Jankovic J
Expert Rev Neurother; 2006 Aug; 6(8):1181-97. PubMed ID: 16893346
[TBL] [Abstract][Full Text] [Related]
6. [Behavioral disorders in Parkinson's disease: from pathophysiology to the mastery of dopaminergic treatment].
Thobois S; Ardouin C; Schmitt E; Lhommée E; Klinger H; Xie J; Lagrange C; Kistner A; Aya Kombo M; Fleury V; Poisson A; Fraix V; Broussolle E; Pollak P; Krack P
Rev Neurol (Paris); 2010 Oct; 166(10):816-21. PubMed ID: 20739041
[TBL] [Abstract][Full Text] [Related]
7. Demographic and motor features associated with the occurrence of neuropsychiatric and sleep complications of Parkinson's disease.
Munhoz RP; Teive HA; Eleftherohorinou H; Coin LJ; Lees AJ; Silveira-Moriyama L
J Neurol Neurosurg Psychiatry; 2013 Aug; 84(8):883-7. PubMed ID: 23463867
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
[TBL] [Abstract][Full Text] [Related]
9. Cognitive impairment in Parkinson's disease.
Girotti F; Marano R; Grazzi L; Scigliano G; Caraceni T
J Neural Transm Suppl; 1986; 22():163-70. PubMed ID: 3465870
[TBL] [Abstract][Full Text] [Related]
10. [Depression in Parkinson's disease and its relation to the cognitive and motor manifestations].
Gil Saladié D; Delgado González M; Oliveras Ley C; Peña Casanova J; Barraquer Bordas L
Neurologia; 1992; 7(7):176-80. PubMed ID: 1419086
[TBL] [Abstract][Full Text] [Related]
11. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease--Part 3: Neuropsychiatric symptoms.
Weintraub D; Comella CL; Horn S
Am J Manag Care; 2008 Mar; 14(2 Suppl):S59-69. PubMed ID: 18402509
[TBL] [Abstract][Full Text] [Related]
13. [Neuropsychiatric and cognitive symptoms in Parkinson disease].
Aarsland D; Pedersen KF; Ehrt U; Bronnick K; Gjerstad MD; Larsen JP
Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2072-6. PubMed ID: 18846124
[TBL] [Abstract][Full Text] [Related]
14. [Neuropsychiatric disorders in Parkinson's disease].
Noé-Sebastián E; Irimia-Sieira P; Pomares-Arias E; Martínez-Vila E; Luquin-Piudo MR
Rev Neurol; 2001 Apr 1-15; 32(7):676-81. PubMed ID: 11391498
[TBL] [Abstract][Full Text] [Related]
15. Relationship between cognitive dysfunction and behavioural symptoms in Nigerian patients with Parkinson's disease no dementia.
Ojagbemi A
J Parkinsons Dis; 2013 Jan; 3(3):293-300. PubMed ID: 23963316
[TBL] [Abstract][Full Text] [Related]
16. Drug therapy for Parkinson's disease.
Hermanowicz N
Semin Neurol; 2007 Apr; 27(2):97-105. PubMed ID: 17390254
[TBL] [Abstract][Full Text] [Related]
17. Urinary 8-hydroxydeoxyguanosine correlate with hallucinations rather than motor symptoms in Parkinson's disease.
Hirayama M; Nakamura T; Watanabe H; Uchida K; Hama T; Hara T; Niimi Y; Ito M; Ohno K; Sobue G
Parkinsonism Relat Disord; 2011 Jan; 17(1):46-9. PubMed ID: 21106430
[TBL] [Abstract][Full Text] [Related]
18. Anxiety disorders in Parkinson's disease: prevalence and risk factors.
Dissanayaka NN; Sellbach A; Matheson S; O'Sullivan JD; Silburn PA; Byrne GJ; Marsh R; Mellick GD
Mov Disord; 2010 May; 25(7):838-45. PubMed ID: 20461800
[TBL] [Abstract][Full Text] [Related]
19. [Non-motor symptoms in Parkinson's disease: cognition and behavior].
Bonnet AM; Czernecki V
Geriatr Psychol Neuropsychiatr Vieil; 2013 Sep; 11(3):295-304. PubMed ID: 24026132
[TBL] [Abstract][Full Text] [Related]
20. [Advanced Parkinson's disease: clinical characteristics and treatment (part 1)].
Kulisevsky J; Luquin MR; Arbelo JM; Burguera JA; Carrillo F; Castro A; Chacón J; García-Ruiz PJ; Lezcano E; Mir P; Martinez-Castrillo JC; Martínez-Torres I; Puente V; Sesar A; Valldeoriola-Serra F; Yañez R
Neurologia; 2013 Oct; 28(8):503-21. PubMed ID: 23856182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
